FTXH ETF
First Trust Nasdaq Pharmaceuticals ETF
MRK is FTXH's largest holding at 7.56% of the fund as of Sep 15, 2026. FTXH is First Trust Nasdaq Pharmaceuticals ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | M | Merck & Company IncHealth Care · Pharmaceuticals | 7.56% | 7.6% | 544,360 | $78.77M | Health Care | Pharmaceuticals |
| 2 | A | AbbVie Inc.Health Care · Pharmaceuticals | 7.11% | 14.7% | 290,461 | $74.07M | Health Care | Pharmaceuticals |
| Sector and industry · Pro | ||||||||
| 3 | J | Johnson & Johnson - | 6.94% | 21.6% | 271,402 | $72.29M | ||
| 4 | L | Eli Lilly & Co. | 6.89% | 28.5% | 63,872 | $71.73M | ||
| 5 | B | Bristol-Myers Squibb Co. | 6.62% | 35.1% | 1,080,978 | $68.91M | ||
| 6 | B | Biogen Inc. | 3.63% | 38.8% | 175,621 | $37.83M | ||
| 7 | V | Viatris Inc. | 3.55% | 42.3% | 2,257,753 | $36.98M | ||
| 8 | — | Vertex Pharmaceuticals Inc | 3.36% | 45.7% | 67,972 | $34.98M | ||
| 9 | C | Cardinal Health Inc. | 3.34% | 49.0% | 147,276 | $34.76M | ||
| 10 | R | Regeneron Pharmaceuticals, Inc. | 3.29% | 52.3% | 43,252 | $34.31M | ||
| 11 | P | Pfizer Inc | 3.24% | 55.5% | 1,219,007 | $33.71M | ||
| 12 | A | Amgen Inc. | 3.20% | 58.7% | 87,024 | $33.28M | ||
| 13 | G | Gilead Sciences | 3.14% | 61.9% | 226,097 | $32.74M | ||
| 14 | I | Incyte Corp. | 2.47% | 64.3% | 208,588 | $25.71M | ||
| 15 | U | United Therapeutics Corp | 2.42% | 66.8% | 49,942 | $25.16M | ||
| 16 | J | Jazz Pharmaceuticals Plc. | 2.35% | 69.1% | 101,979 | $24.52M | ||
| 17 | I | Illumina, Inc. | 2.16% | 71.3% | 111,746 | $22.49M | ||
| 18 | Z | Zoetis Inc, Class A | 1.80% | 73.1% | 256,992 | $18.72M | ||
| 19 | E | Exelixis Inc | 1.73% | 74.8% | 313,636 | $18.01M | ||
| 20 | C | Charles River Laboratories International Inc | 1.70% | 76.5% | 64,890 | $17.71M | ||
| 21 | H | Halozyme Therapeutics Inc | 1.57% | 78.1% | 152,941 | $16.36M | ||
| 22 | M | Medpace Holdings Inc | 1.47% | 79.5% | 26,272 | $15.32M | ||
| 23 | T | 10x Genomics Inc Com Usd 1 Cl A | 1.28% | 80.8% | 201,352 | $13.37M | ||
| 24 | B | Biomarin Pharmaceutical Inc. | 1.21% | 82.0% | 192,620 | $12.62M | ||
| 25 | N | Neurocrine Biosciences Inc | 1.21% | 83.2% | 80,335 | $12.58M | ||
| 26 | T | Twist Bioscience Corp. | 1.20% | 84.4% | 98,876 | $12.54M | ||
| 27 | — | Moderna therapeutics | 1.13% | 85.6% | 86,521 | $11.82M | ||
| 28 | — | Alkermes Plc. Ordinary Shares | 1.13% | 86.7% | 255,454 | $11.78M | ||
| 29 | P | Ptc Therapeutics Inc | 1.08% | 87.8% | 166,341 | $11.21M | ||
| 30 | T | Travere Therapeutics Inc | 1.01% | 88.8% | 155,535 | $10.50M | ||
| 31 | S | Spyre Therapeutics Inc | 0.92% | 89.7% | 107,644 | $9.55M | ||
| 32 | T | Tg Therapeutics Inc | 0.82% | 90.5% | 153,990 | $8.53M | ||
| 33 | G | Guardant Health, Inc | 0.75% | 91.3% | 49,436 | $7.86M | ||
| 34 | E | Elanco Animal Health, Inc Cvr | 0.73% | 92.0% | 333,213 | $7.62M | ||
| 35 | P | Protagonist Therapeutics Inc | 0.70% | 92.7% | 50,463 | $7.33M | ||
| 36 | A | Amneal Pharmaceuticals Inc. | 0.64% | 93.3% | 396,043 | $6.68M | ||
| 37 | L | Ligand Pharmaceuticals, Inc. | 0.64% | 94.0% | 23,186 | $6.71M | ||
| 38 | A | Arrowhead Pharmaceuticals Inc | 0.63% | 94.6% | 79,816 | $6.61M | ||
| 39 | — | Roivant Sciences Ltd. Common Shares | 0.63% | 95.2% | 160,167 | $6.56M | ||
| 40 | R | Arcus Biosciences Inc | 0.57% | 95.8% | 227,628 | $5.95M | ||
| 41 | K | Kymera Therapeutics Inc | 0.57% | 96.4% | 50,972 | $5.96M | ||
| 42 | K | Krystal Biotech Inc | 0.56% | 96.9% | 16,985 | $5.87M | ||
| 43 | A | Acadia Pharmaceuticals Inc | 0.50% | 97.4% | 188,991 | $5.24M | ||
| 44 | M | Mirum Pharmaceuticals, Inc. | 0.49% | 97.9% | 50,457 | $5.08M | ||
| 45 | T | Tarsus Pharmaceuticals Inc | 0.48% | 98.4% | 61,291 | $4.97M | ||
| 46 | A | Arcutis Biotherapeutics Inc | 0.39% | 98.8% | 172,003 | $4.02M | ||
| 47 | S | Supernus Pharmaceuticals Inc | 0.34% | 99.1% | 84,474 | $3.52M | ||
| 48 | A | Alnylam Pharmaceuticals Inc. | 0.33% | 99.5% | 13,906 | $3.44M | ||
| 49 | I | Ionis Pharmaceuticals Inc | 0.31% | 99.8% | 57,163 | $3.18M | ||
| 50 | — | US Dollar | 0.20% | 100.0% | 2,032,975 | $2.03M | ||
FTXH ETF All Holdings
FTXH holdings total 100 positions. The top 10 holdings account for 52.3% of the fund, led by Merck & Company Inc at 7.6%, Abbvie Inc. at 7.1%, Johnson & Johnson - Common at 6.9%.
FTXH portfolio concentration is relatively high, with the top 10 representing 52.3% of total assets. The largest sector exposure is Health Care at 96.4%.
FTXH sectors provide a detailed breakdown. FTXH overlap shows how holdings compare to other funds in your portfolio.
FTXH ETF Holdings
50 of 100 holdings
- 1
Merck & Company Inc
MRKHealth Care7.56% - 2
Abbvie Inc.
ABBVHealth Care7.11% - 3
Johnson & Johnson - Common
JNJHealth Care6.94% - 4
Eli Lilly & Co.
LLYHealth Care6.89% - 5
Bristol-Myers Squibb Co.
BMYHealth Care6.62% - 6
Biogen Inc. Com
BIIBHealth Care3.63% - 7
Viatris Inc.
VTRSHealth Care3.55% - 8
Vertex Pharmaceuticals Incorporated
VRTX:MXUnknown3.36% - 9
Cardinal Health Inc.
CAHHealth Care3.34% - 10
Regeneron Pharmaceuticals, Inc.
REGNHealth Care3.29% - 11
Pfizer Inc
PFEHealth Care3.24% - 12
Amgen Inc.
AMGNHealth Care3.20% - 13
Gilead Sciences
GILDHealth Care3.14% - 14
Incyte Corp.
INCYHealth Care2.47% - 15
United Therapeutics Corp
UTHRHealth Care2.42% - 16
Jazz Pharmaceuticals Plc.
JAZZHealth Care2.35% - 17
Illumina, Inc.
ILMNHealth Care2.16% - 18
Zoetis Inc, Class A
ZTSHealth Care1.80% - 19
Exelixis Inc
EXELHealth Care1.73% - 20
Charles River Laboratories International Inc
CRLHealth Care1.70% - 21
Halozyme Therapeutics Inc
HALOHealth Care1.57% - 22
Medpace Holdings Inc
MEDPHealth Care1.47% - 23
10x Genomics Inc Com Usd 1 Cl A
TXGHealth Care1.28% - 24
Biomarin Pharmaceutical Inc.
BMRNHealth Care1.21% - 25
Neurocrine Biosciences Inc
NBIXHealth Care1.21% - 26
Twist Bioscience Corp.
TWSTHealth Care1.20% - 27
Moderna therapeutics
MRNAHealth Care1.13% - 28
Alkermes Plc. Ordinary Shares
ALKS:IEHealth Care1.13% - 29
Ptc Therapeutics Inc
PTCTHealth Care1.08% - 30
Travere Therapeutics Inc
TVTXHealth Care1.01% - 31
Spyre Therapeutics Inc
SYREHealth Care0.92% - 32
Tg Therapeutics Inc Common Stock
TGTXHealth Care0.82% - 33
Guardant Health, Inc
GHHealth Care0.75% - 34
Elanco Animal Health, Inc Cvr
ELANHealth Care0.73% - 35
Protagonist Therapeutics Inc
PTGXHealth Care0.70% - 36
Amneal Pharmaceuticals Inc.
AMRXHealth Care0.64% - 37
Ligand Pharmaceuticals, Inc.
LGNDHealth Care0.64% - 38
Arrowhead Pharmaceuticals Inc
ARWRHealth Care0.63% - 39
Roivant Sciences Ltd. Common Shares
ROIV:BMHealth Care0.63% - 40
Arcus Biosciences Inc
RCUSHealth Care0.57% - 41
Kymera Therapeutics Inc
KYMRHealth Care0.57% - 42
Krystal Biotech Inc
KRYSHealth Care0.56% - 43
Acadia Pharmaceuticals Inc Common Stock Usd 0.0001
ACADHealth Care0.50% - 44
Mirum Pharmaceuticals, Inc.
MIRMHealth Care0.49% - 45
Tarsus Pharmaceuticals Inc
TARSHealth Care0.48% - 46
Arcutis Biotherapeutics Inc
ARQTHealth Care0.39% - 47
Supernus Pharmaceuticals Inc
SUPNHealth Care0.34% - 48
Alnylam Pharmaceuticals Inc.
ALNYHealth Care0.33% - 49
Ionis Pharmaceuticals Inc
IONSHealth Care0.31% - 50
US Dollar
Other0.20%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Merck & Company Inc | MRK | 7.560% | ||
| 2 | Abbvie Inc. | ABBV | 7.110% | ||
| 3 | Johnson & Johnson - Common | JNJ | 6.940% | ||
| 4 | Eli Lilly & Co. | LLY | 6.890% | ||
| 5 | Bristol-Myers Squibb Co. | BMY | 6.620% | ||
| 6 | Biogen Inc. Com | BIIB | 3.630% | ||
| 7 | Viatris Inc. | VTRS | 3.550% | ||
| 8 | Vertex Pharmaceuticals Incorporated | VRTX:MX | 3.360% | ||
| 9 | Cardinal Health Inc. | CAH | 3.340% | ||
| 10 | Regeneron Pharmaceuticals, Inc. | REGN | 3.290% | ||
| 11 | Pfizer Inc | PFE | 3.240% | ||
| 12 | Amgen Inc. | AMGN | 3.200% | ||
| 13 | Gilead Sciences | GILD | 3.140% | ||
| 14 | Incyte Corp. | INCY | 2.470% | ||
| 15 | United Therapeutics Corp | UTHR | 2.420% | ||
| 16 | Jazz Pharmaceuticals Plc. | JAZZ | 2.350% | ||
| 17 | Illumina, Inc. | ILMN | 2.160% | ||
| 18 | Zoetis Inc, Class A | ZTS | 1.800% | ||
| 19 | Exelixis Inc | EXEL | 1.730% | ||
| 20 | Charles River Laboratories International Inc | CRL | 1.700% | ||
| 21 | Halozyme Therapeutics Inc | HALO | 1.570% | ||
| 22 | Medpace Holdings Inc | MEDP | 1.470% | ||
| 23 | 10x Genomics Inc Com Usd 1 Cl A | TXG | 1.280% | ||
| 24 | Biomarin Pharmaceutical Inc. | BMRN | 1.210% | ||
| 25 | Neurocrine Biosciences Inc | NBIX | 1.210% | ||
| 26 | Twist Bioscience Corp. | TWST | 1.200% | ||
| 27 | Moderna therapeutics | MRNA | 1.130% | ||
| 28 | Alkermes Plc. Ordinary Shares | ALKS:IE | 1.130% | ||
| 29 | Ptc Therapeutics Inc | PTCT | 1.080% | ||
| 30 | Travere Therapeutics Inc | TVTX | 1.010% | ||
| 31 | Spyre Therapeutics Inc | SYRE | 0.920% | ||
| 32 | Tg Therapeutics Inc Common Stock | TGTX | 0.820% | ||
| 33 | Guardant Health, Inc | GH | 0.750% | ||
| 34 | Elanco Animal Health, Inc Cvr | ELAN | 0.730% | ||
| 35 | Protagonist Therapeutics Inc | PTGX | 0.700% | ||
| 36 | Amneal Pharmaceuticals Inc. | AMRX | 0.640% | ||
| 37 | Ligand Pharmaceuticals, Inc. | LGND | 0.640% | ||
| 38 | Arrowhead Pharmaceuticals Inc | ARWR | 0.630% | ||
| 39 | Roivant Sciences Ltd. Common Shares | ROIV:BM | 0.630% | ||
| 40 | Arcus Biosciences Inc | RCUS | 0.570% | ||
| 41 | Kymera Therapeutics Inc | KYMR | 0.570% | ||
| 42 | Krystal Biotech Inc | KRYS | 0.560% | ||
| 43 | Acadia Pharmaceuticals Inc Common Stock Usd 0.0001 | ACAD | 0.500% | ||
| 44 | Mirum Pharmaceuticals, Inc. | MIRM | 0.490% | ||
| 45 | Tarsus Pharmaceuticals Inc | TARS | 0.480% | ||
| 46 | Arcutis Biotherapeutics Inc | ARQT | 0.390% | ||
| 47 | Supernus Pharmaceuticals Inc | SUPN | 0.340% | ||
| 48 | Alnylam Pharmaceuticals Inc. | ALNY | 0.330% | ||
| 49 | Ionis Pharmaceuticals Inc | IONS | 0.310% | ||
| 50 | US Dollar | - | 0.200% |












































